First genetic analysis of brain function and structure using UK Biobank imaging data yields exciting results
10 October 2018
Integrative Neuroimaging Research
Oxford scientists report exciting new insights into the structure and function of the brain using genetic information and detailed brain images from UK Biobank
Gene therapy breakthrough in treating a rare form of blindness
8 October 2018
The positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week’s edition of Nature Medicine.
Our researchers join in science & ideas festival
5 October 2018
Many of our scientists are getting out and about in Oxford from 12-22 October, talking about and demonstrating some of their cutting edge neuroscience research.
Digital insomnia medicine rolled out as major study links sleep to better health
30 September 2018
Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.
Significant progress made on our new research building
26 September 2018
Integrative Neuroimaging Stroke & Dementia
Tuesday 25 September saw the 'topping out' ceremony, with completion on course for next summer
Prestigious Zülch Prize for Angela Vincent
17 September 2018
The 2018 Zülch Prize honours research into autoimmunity in neurological diseases. Angela Vincent shares the award with Jerome Posner and Josep Dalmau.
Young people get a taste of working in our labs
3 September 2018
Four students were placed in our department as part of the In2Science programme this summer.
New research on recovery following intensive care treatment
13 August 2018
Out-of-hours discharge from intensive care is strongly associated with both in-hospital death and ICU readmission.
High instance of shoulder impairment in patients discharged from intensive care
9 August 2018
A team involving our Critical Care Research Group have discovered that patients with severe illnesses treated on intensive care units often have problems with their movement and mobility long after they are discharged from hospital.
NDCN research underpins new European licence for migraine prevention drug
31 July 2018
Novartis receives European licence for Aimovig® (erenumab), the first treatment designed specifically for the prevention of migraine
Change blindness work presented at Digital Humanities Summer School
30 July 2018
Chrystalina Antoniades of the NeuroMetrology Lab delivered a session to these summer school delegates about her work on change blindness with the Ashmolean.
Effectiveness of low dose aspirin dependent on body size
27 July 2018
About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. But a new study suggests a more tailored strategy is required.
More awareness needed about stroke risk after mini-stroke
3 July 2018
Professor Peter Rothwell says more must be done to raise awareness of the need to take rapid action after a mini-stroke in order to reduce the number of major strokes.
Study identifies biomarker for the diagnosis of Amyotrophic Lateral Sclerosis (ALS)
27 June 2018
Our Department collaborated with Oxford BioDynamics and Massachusetts General Hospital, Harvard Medical School.
New Yorker discusses Professor Irene Tracey's work
26 June 2018
Integrative Neuroimaging Research
The New Yorker features our Head of Department Professor Irene Tracey, and her research into the neuroscience of pain.
Neurology features in BBC programme about the JR Hospital
21 June 2018
Clinical Neurology Public engagement
Aarti Jagannath presents the first in a new series about how the NHS changed our world